Primary dyslipidemia and cardiometabolic risk: potential of pitavastatin
The review is devoted to the most important aspects of primary mixed dyslipidemia treatment in patients at high risk with concomitant metabolic comorbidities. Evidences for novel modern approaches regarding primary prevention of cardiovascular events among dyslipidemic patients are considered. The...
Saved in:
| Main Authors: | Berezin A.E., Sheychenko T.V., Berezina T.A., Vishnevaya N.V., Kovalenko N.V., Kulik Z.I., Мoiseenko I.А. |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dnipro State Medical University
2015-06-01
|
| Series: | Medičnì Perspektivi |
| Subjects: | |
| Online Access: | http://medpers.dsma.dp.ua/issues/2015/N2/54-62.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Primary dyslipidemia and cardiometabolic risk: potential of pitavastatin.
by: A. E. Berezin, et al.
Published: (2015-06-01) -
Pitavastatin – a new inhibitor of the HMG-CoA reductase: peculiarities of clinical pharmacology and perspectives of its usage in treatment of cardiovascular diseases
by: Dzyak G.V., et al.
Published: (2013-12-01) -
Evaluation of the Efficacy of Pitavastatin on Pain Response in Rats with Thermal Plantar and Dynamic Plantar Tests
by: Tuba Ozcan Metin, et al.
Published: (2024-12-01) -
Response to letter to the editor: Expanding perspectives on the relationship between statin potency and lipophilicity in Alzheimer’s disease management
by: Mar Garcia–Zamora, et al.
Published: (2025-02-01) -
Age Differences in the Correlation Between the Cardiometabolic Index and Chronic Kidney Disease Risk in Adults With Hypertension
by: Yu Tao, et al.
Published: (2024-12-01)